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Until the mid-1970s, Neisseria meningitidis expressing
the serogroup A capsular polysaccharide caused numerous
epidemics of meningitis and septicemia, with annual
incidence rates >100/100,000 (1). During serogroup A
epidemics, these bacteria can also be isolated from the
nasopharynx of a considerable proportion of the healthy
population (2). After the mid-1970s, large serogroup A
epidemics became rare, except in the so-called Meningitis
Belt in the Sahel region of Africa (3,4). In 1997,
N. meningitidis caused approximately 500,000 cases of
disease and 50,000 deaths worldwide, half of them in Africa
(5). Serogroup A meningococci are currently isolated only
rarely in western Europe and the United States, and a rise in
either the healthy carriage rate or the proportion of serogroup
A cases would be cause for concern.
Epidemic isolates of N. meningitidis have been assigned
to a limited number of clonal groupings, historically by
multilocus enzyme electrophoresis (MLEE) (4) and currently
by multilocus sequence typing (MLST) (6). For MLST,
sequences of housekeeping gene fragments are assigned
different numeric allele designations, even if they differ by
only one nucleotide. The combination of alleles from seven
housekeeping gene fragments is called the sequence type
(ST). Serogroup A bacteria have also been assigned to clonal
groupings by random amplification of polymorphic DNA
(RAPD) (7). These three methods yield largely concordant
results, except that MLST is the most conservative and RAPD
differentiates the largest number of isolates. The clonal
groupings among serogroup A meningococci have been
designated subgroups I through IX according to MLEE (7,8).
Some of these subgroups have not been differentiated by
RAPD analysis (I vs. II, III vs. VIII) (7) or MLST.
Recent epidemic serogroup A disease in Europe has
largely reflected the pandemic patterns of spread of subgroup
III meningococci. After a large subgroup III epidemic in China
in the mid-1960s (8), these bacteria caused an outbreak of
meningococcal disease in 1969 in western Norway (9),
followed in the mid-1970s by a major epidemic in Finland
(10). During the 1970s, subgroup III meningococci were
isolated throughout western and northern Europe (11). In
1987, serogroup A, subgroup III meningococci caused a
meningitis epidemic during the Hajj pilgrimage to Mecca,
Saudi Arabia (12), and healthy pilgrims carried these
bacteria throughout the world. Localized serogroup A disease
was associated with former pilgrims for several years in the
United Kingdom (13) and France (14), but these meningococci
have since largely disappeared from western Europe. Rare
endemic serogroup A disease was associated with subgroup
VI in East Germany in the 1980s (8) and with subgroup IX in
the Netherlands in the early 1990s (7).
Meningococci are naturally transformable and can
import novel alleles from neisseriae that colonize the
nasopharynx (15,16). However, these recombinant strains are
usually lost during the bottlenecks caused by limited
numbers of bacteria being transmitted during epidemic
spread (17). Occasionally, variants pass through these
bottlenecks first, and all subsequent progeny have a common
genetic background different from that of the parental
bacteria (17). Most subgroup III bacteria isolated from the
mid-1960s to the mid-1980s (“pre-Mecca”) had particular
alleles of the hypervariable opaB and opaD loci encoding Opa
(opacity) proteins and the iga locus encoding IgA1 protease. In
contrast, subgroup III bacteria isolated after the 1987 Mecca
epidemic (“post-Mecca”) had other alleles at these three loci
(17). Exceptional isolates with still other alleles at one or
more of these loci were also found in several countries, but
these variants all disappeared during subsequent epidemic
spread (17).
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Data in the English literature about meningococci from
Russia and other areas of eastern Europe are scarce. In recent
decades, most patients with meningitis in Moscow
(population 8.6 million during 1990 to 1999) have been
treated at the Second Moscow Hospital for Infectious
Diseases. Our review of their records shows that from 1980 to
1999, the annual incidence rates of meningitis caused by
Haemophilus influenzae and Streptococcus pneumoniae were
approximately 0.2/100,000 and 0.4/100,000, respectively. In
contrast, several epidemics of meningococcal disease with
much higher incidence rates occurred in Moscow from 1924 to
1998 (Figure 1). Large serogroup A epidemics occurred in
1931 and 1940, followed by a decline in disease incidence until
the late 1960s. In 1968, a serogroup A epidemic began in
Lipezk, Russia, where factory workers had recently arrived
from Vietnam. These immigrants had traveled by rail
through China, where subgroup III disease was prevalent (8).
The incidence rate of meningococcal disease in Moscow and
the proportion of serogroup A isolates remained high until the
1980s. In 1996, a new outbreak of serogroup A disease began,
again initially associated with the Vietnamese community.
During the outbreak peak in early 1996, 50 (34%) of 147
patients with meningococcal disease were Vietnamese, and
all their disease isolates were serogroup A. During the rest of
1996, only 8 (6%) of 145 patients with meningococcal disease
belonged to the Vietnamese community. During 1997 to 1999,
hundreds of thousands of Muscovites were immunized with A
polysaccharide vaccine. The incidence rate and the proportion
of serogroup A isolates decreased and have remained stable
through 1999.
We present data on the molecular epidemiology and
genetic relationships of serogroup A meningococci isolated in
Moscow from 1969 to 1997. The data show that four clonal
groupings have been responsible for successive waves of
disease and that epidemic disease in Moscow since 1994 is
associated with a new subgroup III pandemic.
Materials and Methods
Serogroup A Isolates from Moscow
One hundred three strains of N. meningitidis were
isolated in Moscow from the cerebrospinal fluid or blood of
patients with systemic meningococcal disease or from throat
swabs of their close contacts (seven subgroup VI strains,
1988-89). Strains were serogrouped by immune precipitation
with specific sera and lyophilized. The bacteria we describe
represent almost all the viable serogroup A bacteria still
available in the laboratory collections at the Central Research
Institute of Epidemiology and the Gamaleya Institute of
Epidemiology and Microbiology, with the following excep-
tions: Only one third of the bacteria available from 1969 to
1972 and half the bacteria from 1996 were tested to avoid bias
toward these two periods. The lyophilized bacteria were
purified again by single colony isolation. These bacterial
cultures were then serogrouped, serotyped, and subtyped by
using whole-cell enzyme-linked immunosorbent assay
(ELISA) with monoclonal antibodies (8). DNA was prepared
as described (21) and used for molecular fine typing and MLST.
MLST
Both strands of fragments of abcZ, adk, aroE, gdh, pdhC,
pgm, and fumC were sequenced as described (http://
www.mlst.net), except that primers O1101 (5'TCCGGCT-
TGCCGTTTGTCAG) and O1102 (5'TTGTAGGCGGTTTTG-
GCGAC) were used for fumC. At the beginning of this project,
the MLST database inadequately represented the diversity of
serogroup A meningococci because it contained data for only
36 strains, predominantly from MLEE subgroups I, III, and
IV-1 (6). To enlarge the database, MLST was performed with
66 serogroup A isolates from diverse sources that had
previously been assigned to subgroups II through IX by
MLEE (7,8) and in some cases by RAPD analysis (7). MLST
was also performed with 42 serogroup A isolates from Moscow
chosen from the most diverse branches of the RAPD tree.
Other laboratories had deposited data for eight serogroup A
strains in six novel STs, resulting in 152 serogroup A strains
in 31 STs (Table 1). The results, including strain description,
source, and MLEE assignments, are publicly available (http:/
/www.mlst.net).
Molecular Fine Typing of Subgroup III
Alleles of the four chromosomal opa genes were
determined by restriction analysis of polymerase chain
reaction (PCR) products generated by using one primer in the
upstream conserved flanking DNA and a second HV2-specific
primer, as described (17). The complete opa genes were also
sequenced from selected representative strains.
A fragment of iga was amplified from chromosomal DNA
by using primers O103 and O115 and tested for a BfaI site
that is present in iga1 but not in iga2 or iga3 (17). A different
fragment of iga was amplified with primers O113 and O151
and tested for a DdeI site that is present in iga3 but not iga2
or iga1 (17). In addition, the entire iga gene was amplified
with primers O103 and O152 and sequenced from one ST5
and one ST7 strain.
Figure 1. Annual incidence rates of meningococcal meningitis in Moscow
from 1924 to 1998. Incidence rates were extracted from the compilation
by Bolshakov (18) and data published in annual reports of the Russian
Ministry of Public Health or obtained from 1969 to 1998 by the Central
Research Institute of Epidemiology from epidemiologic investigations in
Moscow. The percentages of serogroup A meningococci among all
meningococci isolated from disease were compiled from various sources
[number of strains]: 1924-1969, Bolshakov (18); 1962-1971, Kostyukova
(19) [300]; 1980-1988, Demina (20) [1,000]; and 1993-1998, Koroleva,
laboratory records [500].422 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
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The IS1106A locus near opcA was amplified by using
primers in conserved DNA flanking this locus (22). Two sizes
of PCR products (4.8 and 3.5 kb) were obtained among the
subgroup III strains. (One strain yielded a 12-kb product that
was not investigated further.) An internal, polymorphic
307-bp stretch was sequenced from one product of each size
and found to differ by 19 bp, including four restriction sites for
HaeIII, ClaI, and BclI. The allele in the 4.8-kb fragment was
named IS1106A10, and the allele in the 3.5-kb fragment was
named IS1106A7. PCR products from all the subgroup III
strains were tested for the four distinctive restriction sites,
but no additional diversity was identified. Details on alleles
at this locus in subgroup III bacteria from sources other than
Moscow have been described (23).
The 2.1-kb tbpB gene was amplified by using an internal
primer located near the ATG start codon (3’-Met2) and a
primer located in the intergenic region between tbpB and tbpA
(5’-Inter1), as described (16). Different alleles of tbpB were
recognized by digesting the 2.1-kb fragment with HaeIII,
MspI, and SspI and by sequencing the entire fragment from
two ST5 strains and one ST7 strain. The tbpB allele
designations are congruent with those described for a 600-bp
5’-terminal region that has been examined from numerous
other strains (16).
To distinguish between pgm3 and pgm19 (6), the pgm
locus was PCR-amplified by using primers O781
(5'-CGGCGATGCCGACCGCTTGG) and O782 (5'GGTGAT-
GATTTCGGTTGCGCC). The PCR products were tested for an
HinfI site that is absent in pgm3 and present in pgm19.
Results
Genetic Relationships of Serogroup A Strains from
Moscow
One hundred three serogroup A N. meningitidis strains
isolated in Moscow during 1969 to 1998 were investigated by
RAPD analysis to elucidate their genetic relationships. The
data (Figure 2) revealed three primary clusters of isolates,
two of which (subgroups III and VI) were assigned to known
clonal groupings by comparison with previous data (7). The
third cluster (24 isolates) differs from previously defined
subgroups and was therefore tentatively designated subgroup
X. Two singleton strains were labeled IV (a strain formerly
assigned to subgroup IV-2 by MLEE) and ST79.
Forty-two strains that represent the diversity revealed by
RAPD were analyzed by MLST. These data were combined
with data from other strains as described in Materials and
Methods, resulting in a database containing 152 serogroup A
isolates (Table 1, Figure 3). MLST did not distinguish several
subgroups defined by MLEE (I and II, IV-1 and IV-2, III and
VIII, V and VII). Otherwise, the subgroup structure in a
neighbor-joining (NJ) tree of the fraction of alleles differing
between STs (Figure 3) was largely concordant with prior
subgroup assignments from MLEE (8) or RAPD (7). Only STs
1 and 57 clustered inappropriately in the NJ tree (Figure 3).
The MLST results confirmed the assignments of isolates
from Moscow to subgroups III and VI. They also demonstrated
that subgroup X is distinct from previously defined subgroups
and is closely related to subgroups I and II. Individual STs of
Table 1. Multilocus sequence typing analysis of serogroup A meningococci
STa MLEE/ RAPD          Sources No. fumC abcZ adk aroE gdh pdhC pgm
21 other UK (1941)   1   1   1   5   1   2 16 17
1 I, II Pandemic (1963-80) 15   1   1   3   1   1   1   3
75 X Moscow (1983-94)   3   1   2   3 25   1   1   3
78 X Moscow (1997)   1   1   2   3 25   1   1 17
76 X Moscow (1983-85)   4 17   2   3   1   1   1   3
77 X Moscow (1984-85)   3   1   2   3   1   1   1   3
69 VI Moscow (1970)   1 28   1   3   4   1   1   3
2 VI Moscow, GDR (1980-95) 17   7   1   3   4   1   1   3
68 VI Moscow (1994-96)   2   7   1   3   4 21   1 17
70 VI Moscow (1984-86)   2   7   1   3   4 22 21   3
73 VI Moscow (1995)   1   7   1   3   4   1 21   3
58 VI GDR (1986)   1   7   1   3 21   1   1   3
71 VI Moscow (1985)   1   7   1   3 10   1   1   3
72 VI Moscow (1987)   1   7   1   3   7   1   1   3
57 II USA (1930-43)   2   1   1   3   1   1   2   3
4 IV-1,IV-2 Pandemic (1917-90) 37   1   1   3   3   4   2   3
80 Gambia (1983)   1 31   1   3 15   4   2   3
203 Gambia (1996)   1   1   1   3   2   3   2   3
5 III,VIII Pandemic (1963-98) 24   1   1   1   2   3   2   3
6 III China (1966)   1   1   1   1   2   3   2 11
7 III Pandemic (1992-96)   9   1   1   1   2   3   2 19
3 V,VII China (1963-87) 11   1   1   3   1   1 23 13
59 V China (1980)   1 22   1 14   1   1 23 13
103 Greece (1996)   1 17   8   4   6   5 18   2
60 IX Holland (1989-92)   4 17 17   5 19   3 26   2
61 IX Holland (1992)   1 17 17 10 19   3 26   2
79 other Moscow (1995)   1 26 12   5   6   9 22   8
299 Czechoslovakia (1972)   1 26   2 29 36 26 18 20
300 Czechoslovakia (1972)   1 26   2 29   9 26 18 20
388 Czechoslovakia (1972)   2 35 57   2   2   6 68 12
400 Czechoslovakia (1972)   1 43 12 16   2   3 37   7
aST = sequence type; GDR = German Democratic Republic (East Germany); MLEE = multilocus enzyme electrophoresis; RAPD = random amplification of
polymorphic DNA.Vol. 7, No. 3, May–June 2001 Emerging Infectious Diseases 423
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these three subgroups share identical alleles for up to six of
the seven gene fragments sequenced (Table 1).
Inconsistent Fine Typing by RAPD and MLST
Subgroup III isolates from Moscow were isolated during
more than one epidemic wave, raising the question whether
these isolates shared a common source. However, the
concordance between RAPD and MLST did not extend below
the subgroup level. The two major RAPD branches in
subgroup III initially seemed to correspond to MLST ST5 and
ST7. These STs are identical except for their pgm alleles (ST5,
pgm3; ST7, pgm19,) which differ by 19 (4%) of 450 bp,
including a distinctive restriction site. Genotyping of pgm
from all subgroup III isolates by PCR-restriction fragment
length polymorphism (PCR-RFLP) showed that both major
RAPD branches contained both pgm alleles (Figure 2).
Therefore, additional powerful fine typing methods, such as
Figure 2. UPGMA tree of band differences between random amplified
polymorphic DNA (RAPD) patterns from 103 serogroup A strains from
Moscow. RAPD tests were performed with primers 1254, 1281, NM03,
and NM04 as described (7), generating four patterns for each strain. The
combination of the differences between these patterns was used to
generate a UPGMA tree with the program GelCompar (Applied Maths,
Kortrijk, Belgium), as described (7). Subgroup designations are
indicated within the tree. The strain designations and the sequence type
(ST) assignments from MLST analysis are shown at the right. For
subgroup III bacteria, dark gray rectangles indicate pgm3 and light gray
rectangles indicate pgm19. Strain Z4714 is indicated as belonging to
subgroup IV because RAPD does not distinguish between subgroups IV-
1 and IV-2.
Figure 3. Midpoint rooted neighbor-joining (NJ) tree of the proportion of
seven housekeeping gene fragments that differed between individual
sequence types (STs) among 152 serogroup A isolates. The ST
designations are indicated at the right of each twig, and the subgroup
designations are shown in bold print in the tree. A scale bar showing the
distance of 0.1 is at the lower left. STs 1 and 57, containing six subgroup
II strains, are widely separated in this tree although they differ only at
the pdhC locus (Table 1). These two STs were on adjacent twigs in a
UPGMA tree (data not shown), but that tree separated STs 3 and 59
(subgroup V), that differ only at two of the seven loci (Table 1) and are on
neighboring twigs in the NJ tree. Given the low number of allelic
differences between STs 1 and 57 and STs 3 and 59, their aberrant
relative positions in one or the other tree were ignored and their former
subgroup assignments have been retained.424 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
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multilocus PCR-RFLP, were needed to resolve whether all
bacteria within a subgroup originated from the same sources.
Serologic Properties
In some cases, serologic serotyping and serosubtyping
can be used to enable rapid recognition of clonal groupings.
The serologic properties of all the serogroup A bacteria from
Moscow were determined by ELISA with monoclonal typing
antibodies. The results confirmed previous results for
subgroups III and VI (8) and showed that subgroup X is
4,21:P1.10 or 21:P1.10 (Table 2). Subgroup X is therefore not
distinguishable by serologic testing from serogroup A
subgroups I, II, IV-2 and VI, which are also 4,21:P1.10. The
subgroup III strains uniformly expressed the class I and IIa
pilin epitopes (8); however, the pilin epitopes of subgroups VI
and X were not uniform: half of each group of strains expressed
class I and IIa epitopes and the other half the class IIb epitope.
Thus, except for subgroup III, serologic typing would not be
useful for distinguishing these various subgroups.
Successive Waves Caused by Different Clonal Groupings
The three subgroups were isolated in Moscow during four
successive waves of disease caused, respectively, by ST5 of
subgroup III (1969 to 1977, 17 of 19 isolates), subgroup X
(1983 to 1985; 21 of 27), subgroup VI (1986 to 1995; 32 of 36)
and ST7 of subgroup III (1996-97; 19 of 21) (Table 3). The
isolation of subgroup III bacteria correlated with epidemic
peaks of disease in 1970 and 1996 (Figure 1); in both cases,
subgroup III bacteria were also isolated in Moscow 1 to 2 years
before the peak epidemic year (Table 3). In contrast, the
isolation of subgroup X or subgroup VI did not correlate with
an increase in the incidence rate for serogroup A disease. The
slight increase in disease incidence in the mid-1980s was
associated with serogroup B meningococci.
Molecular Fine Typing of Subgroup III Isolates
Both pre-Mecca and post-Mecca isolates are ST5, while
the subgroup III meningococci isolated in Moscow since the
mid-1990s are ST7. PCR-RFLP of the opaB, opaD and iga loci
distinguished pre-Mecca from post-Mecca bacteria (17) but
did not allow unambiguous assignment of the isolates from
Moscow to either of these two waves. To resolve the fine
structure of subgroup III, we identified three additional
distinctive molecular markers, tbpB, IS1106A, and pgm,
which were tested by PCR-RFLP plus sequencing for
numerous subgroup III isolates from other countries (23).
PCR-RFLP of these six variable loci subdivides subgroup III
bacteria into nine so-called genoclouds, each containing a
spectrum of related genotypes, and shows that a third wave of
pandemic disease caused by genocloud 8 began in eastern
Asia in the early 1990s. Genocloud 8 bacteria differ from other
subgroup III meningococci in having the tbpB55, pgm19, and
IS1106A7 alleles (Table 4). All 21 subgroup III bacteria
isolated in Moscow from 1994 to 1997 also have these alleles
(Table 4) and thus represent an extension of the third
pandemic wave.
The subgroup III ST5 meningococci isolated in Moscow
from 1969 to 1977 are distinct from all other subgroup III
meningococci and define genocloud 2 (Table 4). The most
closely related genocloud is genocloud 1, isolated in China in
the mid-1960s, which contains the same IS1106A10 element
but differs at tbpB and opaB. The genocloud 3 bacteria that
caused outbreaks in northern Europe concurrently with the
epidemic in Moscow differed in IS1106A (IS1106A4) as well as
tbpB and opaB. Other subgroup III genoclouds, including
genocloud 5 (post-Mecca), differed at even more loci (Table 4).
Phylogenetic Ancestry of Genocloud 2
The unique tbpB allele in ST5 subgroup III bacteria from
Moscow is not informative for phylogenetic descent: It was not
found in any other genocloud and was probably imported by
DNA transformation (16) shortly before or after these
bacteria arrived in Moscow. However, the phylogenetic
history of the unique opaB alleles in the subgroup III bacteria
from Moscow can be reconstructed from their sequences.
Genocloud 1 bacteria from China have the opa132, opa92,
opa131, and opa101 alleles at the opaA, B, D, and J loci,
respectively. The novel alleles at the opaB and opaD loci in
genocloud 2 bacteria from Moscow probably represent gene
conversion with the opaJ101 and opaA132 alleles (Figure 4).
The opaB140 allele, which was present in all but one strain
from Moscow (Table 4), differs from opaJ101 by only one
nucleotide (Figure 4). The opaB113 allele (one strain) can be
explained by gene conversion of opaB140 with DNA from the
opaA132 allele. opaD131 is present in genocloud 1 and was
Table 3. Years of isolation of individual subgroups of serogroup A
Neisseria meningitidis in Moscow
                             Number of strains
Year III (ST5a)  X VI III (ST7) other Total
1969   1     1
1970   9   1   10
1971   4 1     5
1973   1     1
1977   2     2
1983   4     4
1984 14   3   17
1985   3   3     6
1986   3     3
1987   3     3
1988   8     8
1991   8     8
1993   2     2
1994   1   4   1     6
1995   4   1 1     6
1996   1 17   18
1997   1   2     3
Total 17 23 40 21 2 103
aST = sequence type
Subgroup assignments are according to data from random amplification of
polymorphic DNA (Figure 2). For strains of subgroup III where a complete
multilocus sequence typing analysis was not performed, bacteria were
assigned to ST5 and ST7 on the basis of results with pgm polymerase chain
reaction/restriction analysis. Other: 1971, subgroup IV-2; 1995, ST79.
Table 2. Serologic properties of serogroup A meningococci from Moscow
Subgroup Proportion (%) Serotype Serosubtype
III 34/38 (89)    21 P1.20,9
VI  6/39 (15)    21 P1.10
VI 12/39 (31) 4,21 P1.10
VI 17/39 (44) 4,21 P1.5,10
X 17/24 (71) 4,21 P1.10
X  6/24 (25)    21 P1.10Vol. 7, No. 3, May–June 2001 Emerging Infectious Diseases 425
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also found in all but two genocloud 2 strains from Moscow. The
two exceptional strains contain the opaD109 and opaD110
alleles, which could easily have arisen by gene conversion of part
of the opaD131 locus with DNA from the opaJ101 locus.
Discussion
Since the 1920s, serogroup A meningococci have been
responsible for a large proportion of the bacterial meningitis
in Moscow (Figure 1). Serogroup A meningococci isolated in
Moscow from 1969 to 1997 (103 isolates) were analyzed by
RAPD. Strains representing the diversity revealed by the
RAPD data were analyzed by MLST (44 isolates), and all 38
subgroup III strains were subjected to molecular fine typing
by multilocus PCR-RFLP. The results illustrate the
limitations of these methods and yield important information
about the phylogenetic relationships among serogroup A
meningococci. They also demonstrate that serogroup A
meningococcal disease in Moscow since 1969 has been caused
by four successive, independent waves of bacterial
colonization, most recently by the spread of a third subgroup
III pandemic wave from East Asia.
Typing Methods
RAPD analysis was used to provide a quick overview of
the genetic diversity in the 103 strains investigated
(Figure 2). This information was used to select a smaller
group of bacteria to be tested by more expensive and labor-
intensive methods such as MLST. As in previous comparisons
between RAPD and MLEE (7), the subgroup assignments
were concordant between MLST and RAPD. The RAPD data
allowed the initial recognition of a new subgroup, subgroup X,
and the MLST data confirmed that subgroup IX is not
genetically related to the epidemic serogroup A subgroups as
originally demonstrated by RAPD data (7). Thus, RAPD
analysis can be a highly reliable, quick method for recognizing
genetically related bacterial groups.
Finer subdivisions in subgroups III and X, suggested by
the RAPD data, were contradicted by MLST results. ST76 was
distributed among both primary RAPD subdivisions of the
subgroup X cluster, and the two primary RAPD subdivisions
of the subgroup III cluster did not correlate with presence of
pgm3 versus pgm19 (Figure 2) or with epidemiologic data.
Such random noise will probably be most extreme for bacteria
such as N. meningitidis, which frequently import DNA from
unrelated neisseriae (15). Thus, putative subdivisions within
phylogenetically related groups suggested by RAPD data
should be confirmed by independent methods.
MLST is based on sequences of conserved housekeeping
genes and sequence variants are rarer than with most other
methods used in molecular epidemiology, thus facilitating
global, long-term epidemiology (6). For subgroup III, the
distinction between STs 5 and 7 based on pgm is a very useful
molecular marker for recognizing bacteria from the third
pandemic wave. However, the epidemiologic data do not
suggest that other STs are useful markers for genetic variants
that have spread extensively, and MLST does not necessarily
provide the discrimination desired for fine typing.
Unfortunately, the fine structure of bacteria that
frequently import foreign DNA is very difficult to resolve, and
we know of no method that is eminently suitable for this task.
Our data argue against the use of RAPD and MLST. Although
pulsed-field gel electrophoresis is highly suitable for
differentiating almost identical bacteria in limited numbers
of strains (17,24,25), it is poorly suited for elucidating the
relationships among large numbers of less strongly related
bacteria. Fine typing was therefore attempted based on
multilocus RFLP of PCR fragments of pgm plus the variable
genes opa, iga, and tbpB and the IS1106A element. Multilocus
PCR-RFLP of variable genes allowed molecular fine typing
within subgroup III meningococci, but the data are also
limited by considerable random noise, resulting in genoclouds
of related variants (23). Alternative strategies involving IS
Table 4. Hypervariable alleles among subgroup III meningococci isolated in Moscow
Locus
Strains No. tbpB iga pgm IS1106 opaA opaB opaD opaJ
agenocloud 1   1 2   3 A10 132   92 131 101
genocloud 3   1 2   3 A4 132   92 131 101
genocloud 5   1 3   3 A4 132   94 100 101
genocloud 8 55 2 19 A7 132   92 131 101
Moscow genocloud 2
  1969-1973 14 38 2   3 A10 132 140 131 101
  1970   1 38 2   3 A10 132 113 131 101
  1977   1 38 2   3 A10 132 140 110 101
  1977   1 38 2   3 ndb 132 140 109 101
Moscow genocloud 8
  1994-1997 21 55 2 19 A7 132   92 131 101
aData for the genoclouds at the top of the table are from a separate manuscript (23). Sources of genoclouds: 1, China, 1966; 3, pre-Mecca isolates (1969-1984) from
Europe, Brazil and China; 5, post-Mecca isolates (1987-1998) from Africa and pilgrims returning from Mecca in 1987 to various countries; and 8, China, Mongolia,
and Africa, 1993-2000. All serogroup A isolates from Moscow that were assigned to subgroup III by random amplification of polymorphic DNA are included in this
table. The opaA and opaJ alleles have not been tested in all bacteria from the various genoclouds because they are otherwise so uniform.
bnd = not determined because this strain yields an unusual 12-kb polymerase chain reaction product for the IS1106A region.
Figure 4. Sequence differences among opa alleles found in genocloud
2 subgroup III serogroup A meningococci from Moscow. Each vertical
line represents a nucleotide different from the consensus sequence.
Hatched rectangles indicate identical stretches that are inferred to
represent gene conversion.426 Emerging Infectious Diseases Vol. 7, No. 3, May–June 2001
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elements (26), amplified fragment-length polymorphism (27),
or variable nucleotide repeat sequences (28) have been used
successfully for fine typing of highly uniform microorganisms.
Such methods have not yet been extensively tested with
N. meningitidis but seem likely to be limited by at least as
much random noise as the methods we used. Thus, reliable
fine typing remains difficult to achieve.
Phylogeny of Serogroup A Meningococci
The MLST data on 152 serogroup A strains allow
inferences about the evolution of these bacteria. The STs in
subgroups I through VIII and X (the epidemic subgroups)
probably stem from a common ancestor. They form a
monophyletic clade in phylogenetic trees (Figure 3), and many
of these STs share the fumC1, abcZ1, adk3, gdh1, pdhC1, and
pgm3 alleles (Table 1). The epidemic subgroups include
meningococci isolated since the beginning of this century
(ST4, subgroup IV-2, 1917; ST57, subgroup II, 1930) (8) and
must have evolved before then.
Older isolates of subgroups III (1960s), IV-1 (1960s), and
IV-2 (1917) had identical or nearly identical opa, iga, and
tbpB alleles (16,17), whereas more recent isolates have
imported novel alleles at these loci. These data indicate that
the common ancestor of these three subgroups existed
approximately 100 years ago (17).
The branch lengths (Figure 3) and common alleles
indicate that the epidemic subgroups are probably not much
older than the split between subgroups III, IV-1, and IV-2.
The epidemic serogroup A subgroups may therefore have
descended from a common ancestor that existed within the
last few hundred years. Epidemic meningitis was first
observed in Geneva in 1805 (29), and that epidemic may have
marked the evolution of serogroup A after the import of the
sacA-D genes encoding the A polysaccharide. Horizontal
exchange between serogroups B and C of genes encoding
capsular polysaccharides has been documented (30), and
more than one capsular polysaccharide serogroup is present
in several of the otherwise uniform STs in the complete MLST
database. Furthermore, the sacA-D genes are characterized
by an unusually low GC content (31), as if these genes were
recently imported from an unrelated species. If this
speculation is correct, the other serogroup A bacteria (Figure
3, bottom) may represent unrelated N. meningitidis that have
imported  sacA-D genes from the epidemic subgroups.
Alternatively, the sacA-D genes may have been imported from
an unrelated species more than once, or the epidemic
subgroups may have imported the sacA-D from one of the
nonepidemic STs (Figure 3, bottom). Analysis of the sequence
diversity of the sacA-D genes in various STs might resolve
these alternative explanations.
Molecular Epidemiology
Evaluation of the long-term molecular epidemiology of
bacterial pathogens within a global context is complex,
requiring large, representative strain collections and reliable,
preferably phylogenetically based, typing schemes. Our
results illustrate both strengths and weaknesses in our
knowledge of serogroup A epidemiology.
The assignment of genocloud 8 bacteria isolated in the
mid-1990s in Moscow to the third subgroup III pandemic
wave is straightforward and indisputable. It rests on three
unusual markers (pgm19, tbpB55, and IS1106A7), and no
differences in these three markers were detected among
recent subgroup III isolates from China, Mongolia, Africa,
and Russia. The initial association of genocloud 8 disease in
Moscow with the Vietnamese community remains unex-
plained.
The genocloud 2 subgroup III bacteria from the early
1970s differ at the opaB  and  tbpB loci from all known
subgroup III meningococci. We argue that genocloud 2 is
probably derived from genocloud 1 in China because of the
shared IS1106A10 allele, which was not found in any other
subgroup III bacteria. In support of this interpretation based
on molecular data, this epidemic first broke out among
Vietnamese immigrants who had traveled through China en
route to Russia. However, few subgroup III strains exist that
were isolated before 1969, and our knowledge about the
diversity and patterns of serogroup A disease before 1969 is
only fragmentary.
Subgroup VI bacteria of serogroups A, B, and C were
occasionally isolated from endemic disease in East Germany
in the 1980s (8). Our data show that most of the serogroup A
meningococci isolated during 1986 to 1994 in Moscow were
also subgroup VI, and these bacteria may have been widely
distributed in eastern Europe in the 1980s. In contrast,
subgroup X, common in Moscow during 1983 to 1985, has not
been described previously. Various STs (Figure 3, bottom)
have also been isolated only from single countries (subgroup
IX in the Netherlands during 1989 to 1993 [7]; STs 299, 300,
388, and 400 in Czechoslovakia in 1972 [K. Jolley and P. Kriz,
pers. comm.]; ST79 in Moscow in 1995; and ST103 in Greece in
1996 [R. Urwin, pers. comm.]). These bacteria have
apparently not spread extensively, unlike the epidemic
subgroups. In this respect, they resemble most endemic
serogroup B meningococci, such as those identified by MLEE
among endemic disease isolates from the Netherlands (32)
and carrier isolates from Norway (33). Additional serogroup A
STs specific to certain countries or regions probably remain to
be identified. Current meningococcal strain collections
containing a few thousand isolates are probably one or two
orders of magnitude too small to yield reliable epidemiologic
data for unusual STs that have not caused larger disease
outbreaks.
Subgroup III has caused large disease outbreaks, and its
molecular epidemiology has been extensively investigated
(11,17,23). As a result, the available information on genetic
changes during pandemic spread of these bacteria is among
the most extensive for any bacterial pathogen. Our data show
that the extensive pandemic spread of these bacteria is likely
to continue. Although Moscow and western Europe differ
somewhat in epidemiologic patterns, the recent extension of
this third pandemic wave to Moscow warns us that we should
be prepared for new, large serogroup A outbreaks in countries
in both eastern and western Europe.
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